Versant Capital Management, Inc

Position in DNLI — Denali Therapeutics Inc.

CIK 1735057 PHOENIX, AZ

Position in DNLI

as of Jun 30, 2026 · filed Jul 2, 2026 Compact

Position Value

$42,000

+$13,661 QoQ

Shares Held

1,633

+10.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#212

of 290 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Versant Capital Management, Inc holds $5,555,601 across 126 Biotechnology names. DNLI ranks #28 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	2,357	$567,966
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,055	$524,050
3	ARGX	Argenx SE	419	$388,735
4	GMAB	Genmab A/S	11,712	$321,728
5	REGN	Regeneron Pharmaceuticals, Inc.	344	$214,497
6	CELC	Celcuity Inc.	1,630	$170,530
7	MRNA	Moderna, Inc.	2,189	$153,295
8	BMRN	Biomarin Pharmaceutical Inc	2,549	$145,853

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$42,000	1,633	+10.6%	Shares	Sole	2026-07-02
2026-03-31	$28,339	1,476	0.0%	Shares	Sole	2026-04-07
2025-12-31	$24,368	1,476	0.0%	Shares	Sole	2026-01-08
2025-09-30	$21,431	1,476	+14.8%	Shares	Sole	2025-10-27
2025-06-30	$17,991	1,286	+79.6%	Shares	Sole	2025-07-07
2025-03-31	$9,734	716	+252.7%	Shares	Sole	2025-04-03
2024-12-31	$4,137	203	0.0%	Shares	Sole	2025-01-03
2024-09-30	$5,913	203	+101.0%	Shares	Sole	2024-10-07
2024-06-30	$2,345	101	-7.3%	Shares	Sole	2024-07-08
2024-03-31	$2,236	109	+1262.5%	Shares	Sole	2024-04-03
2023-12-31	$171	8	-55.6%	Shares	Sole	2024-01-08
2023-06-30	$531	18	—	Shares	Sole	2023-07-10
No filing history on record for this holder in this stock.